Cai Z, McCaslin P P
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson 39216-4505.
Brain Res. 1993 May 21;611(2):181-6. doi: 10.1016/0006-8993(93)90501-d.
The acute and chronic effects of several anesthetic barbiturates, in therapeutic concentrations, on the excitatory amino acid (EAA)-induced elevation of intracellular calcium levels ([Ca2+]i) were examined in neuronal tissue culture. The ultrashort-acting barbiturate, thiamylal, was effective in blocking elevations of [Ca2+]i induced by kainate, N-methyl-D-aspartate (NMDA), and quisqualate or by membrane depolarization with 40 mM KCl. The structurally similar barbiturate, secobarbital which differs from thiamylal only by having an oxygen in place of a sulfur, was able to block elevations induced by the above EAAs but was less effective than thiamylal and did not significantly reduce [Ca2+]i that resulted from membrane depolarization with KCl. Pentobarbital, while differing from secobarbital by only a methyl group, was without effect on either the NMDA- or 40 mM KCl-induced elevations of [Ca2+]i. By contrast, cyproheptadine, a compound that has been shown to block Ca2+ channels, has a different profile from the above barbiturates in that cyproheptadine is more effective in blocking elevation of [Ca2+]i induced by membrane depolarization with KCl while the barbiturates are more effective in reducing [Ca2+]i induced by EAAs. An anticonvulsant barbiturate, phenobarbital, did not reduced elevations of [Ca2+]i induced by any EAA tested or by membrane depolarization with KCl. When cells were treated chronically with thiamylal for 4 days, 2-6 h after the abrupt drug withdrawal there was a hyperresponsiveness to the elevations of [Ca2+]i induced by both kainate and NMDA but not by quisqualate. A similar hyperresponsiveness was not seen after the chronic treatment with phenobarbital.(ABSTRACT TRUNCATED AT 250 WORDS)
在神经元组织培养中,研究了几种麻醉性巴比妥酸盐在治疗浓度下对兴奋性氨基酸(EAA)诱导的细胞内钙水平([Ca2+]i)升高的急性和慢性影响。超短效巴比妥酸盐硫喷妥钠能有效阻断由 kainate、N-甲基-D-天冬氨酸(NMDA)、喹啉酸或 40 mM KCl 膜去极化诱导的[Ca2+]i 升高。结构相似的巴比妥酸盐司可巴比妥与硫喷妥钠的区别仅在于用氧取代了硫,它能够阻断上述 EAA 诱导的升高,但效果不如硫喷妥钠,并且对 KCl 膜去极化导致的[Ca2+]i 没有显著降低作用。戊巴比妥与司可巴比妥仅相差一个甲基,对 NMDA 或 40 mM KCl 诱导的[Ca2+]i 升高均无影响。相比之下,已证明能阻断 Ca2+通道的化合物赛庚啶与上述巴比妥酸盐的作用模式不同,赛庚啶在阻断 KCl 膜去极化诱导的[Ca2+]i 升高方面更有效,而巴比妥酸盐在降低 EAA 诱导的[Ca2+]i 方面更有效。抗惊厥巴比妥酸盐苯巴比妥对任何测试的 EAA 或 KCl 膜去极化诱导的[Ca2+]i 升高均无降低作用。当细胞用硫喷妥钠慢性处理 4 天后,在突然停药后 2 - 6 小时,对 kainate 和 NMDA 诱导的[Ca2+]i 升高出现高反应性,但对喹啉酸诱导的升高无此现象。苯巴比妥慢性处理后未观察到类似的高反应性。(摘要截短至 250 字)